LogicBio Therapeutics, Inc. (NASDAQ: LOGC) Long Term Investor Notice: Investigation of Potential Wrongdoing
An investigation on behalf of current long term investors in LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares over possible breaches of fiduciary duty by certain officers and directors was announced.
View full press release